Skip to main content
Log in

Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

This study evaluated the effects of mitoxantrone (MX), an antitumor agent, as a sensitizer to both photodynamic and radiation therapy in DFW human melanoma cells. Cells were incubated with MX at different concentrations for 90 min and then exposed to non-coherent light at different fluence rates and/or X-ray ionizing radiation at different dose rates. Combinatorial effects of this chemo-, photo-, and radiotherapy were also evaluated. MX had no significant effects on viability at moderate doses but had a strong cytotoxic effect on cancer cells when used as a photosensitizer. MX also acted as a potent radiosensitizer. We observed a dose-dependent effect on cell viability in cells exposed to MX in combination with phototherapy and radiotherapy. Strong synergistic effects were observed for combinations of two or more treatment methods, which, in some cases, induced complete cell death. Thus, a combination of ionizing radiation with MX-mediated photodynamic therapy could serve as a new method for cancer therapy with fewer adverse side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Garbe C, Blum A (2001) Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 14:280–290

    Article  PubMed  CAS  Google Scholar 

  2. Oppermann M, Geilen CC, Fecker LF, Gillissen B, Daniel PT, Eberle J (2005) Caspase independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk/Bik. Oncogene 24:7369–7380

    Article  PubMed  CAS  Google Scholar 

  3. Helmbach H, Rossmann E, Kern MA, Schadendorf D (2001) Drug-resistance in human melanoma. Int J Cancer 93:617–622

    Article  PubMed  CAS  Google Scholar 

  4. Garbe C, Peris K, Hauschild A et al (2010) Eggermont, diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 46:270–283

    Article  PubMed  Google Scholar 

  5. Berk LB (2008) Radiation therapy as primary and adjuvant treatments for local and regional melanoma. Canc Contr 15:233–237

    Google Scholar 

  6. Baas P, Murrer L, Zoetmulder FAN et al (1997) Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 76:819–826

    Article  PubMed  CAS  Google Scholar 

  7. Sabel MS, Sondak VK (2003) Pros and cons of adjuvant interferon in the treatment of melanoma. Oncologist 8:451–458

    Article  PubMed  CAS  Google Scholar 

  8. Kiesslich T, Krammer B, Plaetzer K (2006) Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 13:2189–2204

    Article  PubMed  CAS  Google Scholar 

  9. Milanesio ME, Morán FS, Yslas EI, Alvarez MG, Rivarola V, Durantini EN (2001) Synthesis and biological evaluation of methoxyphenyl porphyrin derivatives as potential photodynamic agents. Bioorg Med Chem 9:1943–1949

    Article  PubMed  CAS  Google Scholar 

  10. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380–387

    Article  PubMed  CAS  Google Scholar 

  11. Dougherty TJ (1987) Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol 45:879–889

    Article  PubMed  CAS  Google Scholar 

  12. Kukielczak B, Cieszka KA, Matuszak ZT, Subczynski WK (1995) Experimental photodynamic therapy of Bomirski hamster melanoma using merocyanine 540 and visible light. Curr Top Biophys 19:6–70

    Google Scholar 

  13. Chedekel MR (1995) Photophysics and photochemistry of melanin. In: Zeise L, Chedekel MR, Fitzpatrick TB (eds) Melanin: its role in human photoprotection. Valdenmar Publ Co, Overland Park, pp 11–21

    Google Scholar 

  14. Dun FE (1984) Biologic and biochemical effects of mitoxantrone. Semin Oncol 11:3–10

    Google Scholar 

  15. Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM (1989) Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res 49:4542–4549

    PubMed  CAS  Google Scholar 

  16. Lenk H, Muller U, Tanneberger S (1987) Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics. Efficacy in the treatment of solid tumors and lymphomas, and toxicity. Anticancer Res 7:1257–1264

    PubMed  CAS  Google Scholar 

  17. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Shakeri Zadeh A, Aledavood A (2012) Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer. Photodiagnosis Photodyn Ther 9:46–51

    Article  PubMed  CAS  Google Scholar 

  18. Jassem J, Begg AC, Stewart F, Bartelink H (1995) Combined chemotherapy and radiotherapy. In: Peckham M, Pinedo HM, Veronesi U (eds) Oxford textbook of oncology. Oxford University Press, Oxford, pp 811–823

    Google Scholar 

  19. Toledano A, Azria D, Garaud P et al (2007) Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. J Clin Oncol 25:405–410

    Article  PubMed  CAS  Google Scholar 

  20. Valagussa P, Zambetti M, Biasi S, Moliterni A, Zucali R, Bonadonna G (1994) Cardiac effects following adjuvant chemotherapy and beast irradiation in operable breast cancer. Ann Oncol 5:209–216

    Article  PubMed  CAS  Google Scholar 

  21. Colasanti A, Kisslinger M, Quarto M, Riccio P (2004) Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model. Acta Biochim Pol 51:1039–1046

    PubMed  CAS  Google Scholar 

  22. Prinsze C, Penning LC, Dubbelman TMAR, Van Steveninck J (1992) Interaction of photodynamic treatment and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, Chinese hamster ovary cells, and T24 human bladder cells. Cancer Res 52:117–120

    PubMed  CAS  Google Scholar 

  23. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Aledavood A (2012) The effects of combined treatment with ionizing radiation and Indocyanine green-mediated photodynamic therapy on breast cancer cells. J Photochem Photobiol B 2 109:42–49

    Article  CAS  Google Scholar 

  24. Hammer-Wilson MJ, Sun CH, Ghahramanlou M, Berns MW (1998) In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers. Lasers Surg Med 23:274–280

    Article  PubMed  CAS  Google Scholar 

  25. Sternberg ED, Dolphin D (1993) Second-generation photodynamic agents: a review. J Clin Laser Med Surg 11:233–241

    PubMed  CAS  Google Scholar 

  26. Kanofsky JR, Sima PD (2000) Preferential cytotoxicity for multidrug-resistant K 562 cells using the combination of a photosensitizer and a cyanine dye. J Photochem Photobiol B 54:136–144

    Article  PubMed  CAS  Google Scholar 

  27. Reszka K, Kolodziejczyk P, Tsoungas PG, Lown JW (1988) Photosensitization by antitumor agents. 6. Production of superoxide radical and hydrogen peroxide during illumination of diaminoanthracenediones in the presence of NADH in aqueous solutions: an EPR study. Photochem Photobiol 47:297–304

    Article  Google Scholar 

  28. Reszka K, Lown JW (1989) Photosensitization of anticancer agents. 8. One-electron reduction of mitoxantrone: an EPR and spectrophotometric study. Photochem Photobiol 50:625–633

    Article  Google Scholar 

  29. Andreoni A, Colasanti A, Roberti G (1992) Excited singlet state properties of anthracenedione photosensitizers. J Photochem Photobiol B 14:319–328

    Article  PubMed  CAS  Google Scholar 

  30. Myers CE, Mimnaugh E, Yeh G, Sinha BK (1988) Biochemical mechanisms of tumor cell kill by the anthracyclines. In: Lown JW (ed) Anthracycline and anthracenedione-based anticancer agents. Elsevier, New York, pp 131–162

    Google Scholar 

  31. Paiva MB, Saxton RE, Letts G et al (1996) Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma cells. Laryngoscope 106:257–262

    Article  PubMed  CAS  Google Scholar 

  32. Lanks KW, Gao JP, Sharma T (1994) Photodynamic enhancement of doxorubicin cytotoxicity. Cancer Chemother Pharmacol 35:17–20

    Article  PubMed  CAS  Google Scholar 

  33. Ramakrishnan N, Clay ME, Friedman LR, Antunez AR, Oleinick NL (1990) Post-treatment interactions of photodynamic and radiation induced cytotoxic lesions. Photochem Photobiol 52(3):555–559

    Article  PubMed  CAS  Google Scholar 

  34. Mateos S, Hajji N, Pastor N, Cortés F (2006) Modulation of radiation response by inhibiting topoisomerase II catalytic activity. Mutat Res 599(1–2):105–115

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Mashhad University of Medical Sciences, Mashhad, Iran.

Conflict of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amirhossein Ahmadi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sazgarnia, A., Montazerabadi, A.R., Bahreyni-Toosi, M.H. et al. Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells. Lasers Med Sci 28, 1533–1539 (2013). https://doi.org/10.1007/s10103-013-1275-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-013-1275-8

Keywords

Navigation